These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10520044)

  • 1. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
    MacLean RM; Feeney GP; Bowley SJ; Bowen DJ; Worwood M; Collins PW
    Br J Haematol; 1999 Oct; 107(1):210-2. PubMed ID: 10520044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation.
    Brown K; Luddington R; Taylor SA; Lillicrap DP; Baglin TP
    Br J Haematol; 1999 Apr; 105(1):95-7. PubMed ID: 10233369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden as a common genetic risk factor for venous thromboembolism.
    Horne MK; McCloskey DJ
    J Nurs Scholarsh; 2006; 38(1):19-25. PubMed ID: 16579319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
    De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
    Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany.
    Nielsen P; Carpinteiro S; Fischer R; Cabeda JM; Porto G; Gabbe EE
    Br J Haematol; 1998 Dec; 103(3):842-5. PubMed ID: 9858243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients.
    Lüdemann P; Nabavi DG; Junker R; Wolff E; Papke K; Buchner H; Assmann G; Ringelstein EB
    Stroke; 1998 Dec; 29(12):2507-10. PubMed ID: 9836759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss.
    Wüthrich RP; Cicvara-Muzar S; Booy C; Maly FE
    Transplantation; 2001 Aug; 72(3):549-50. PubMed ID: 11502996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
    Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
    Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred to venous thrombosis.
    Lellouche F; Dorval I; Corvisier JM; Jézéquel P; Campion L
    Blood; 1999 Mar; 93(6):2135-6. PubMed ID: 10189207
    [No Abstract]   [Full Text] [Related]  

  • 19. Activated protein C resistance and factor V Leiden: a review.
    Rosendorff A; Dorfman DM
    Arch Pathol Lab Med; 2007 Jun; 131(6):866-71. PubMed ID: 17550313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFE mutations, iron deficiency and overload in 10,500 blood donors.
    Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
    Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.